User Image Cart Icon 0 Search Image

Monkeypox

  1. Human monkeypox
  2. Human monkeypox: an emerging zoonosis
  3. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures
  4. Human monkeypox, 1970-79
  5. Human monkeypox: clinical features of 282 patients
  6. The detection of monkeypox in humans in the Western Hemisphere
  7. Reemergence of human monkeypox in Nigeria, 2017
  8. A tale of two clades: monkeypox viruses
  9. Human monkeypox
  10. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997.
  11. Human monkeypox: confusion with chickenpox.
  12. Two cases of monkeypox imported to the United Kingdom, September 2018
  13. Human monkeypox: an emerging zoonotic disease
  14. Human monkeypox: a study of 2,510 contacts of 214 patients
  15. Emergence of monkeypox—west and central Africa, 1970–2017
  16. monkeypox transmission and pathogenesis in prairie dogs
  17. The transmission potential of monkeypox virus in human populations
  18. Clinical characteristics of human monkeypox, and risk factors for severe disease
  19. Re-emergence of human monkeypox in Zaire in 1996.
  20. monkeypox virus: ecology and public health significance
  21. Human monkeypox: secondary attack rates
  22. Re-emergence of monkeypox in Africa: a review of the past six years
  23. monkeypox virus
  24. Emergence of monkeypox as the most important orthopoxvirus infection in humans
  25. Diagnosis of imported monkeypox, Israel, 2018
  26. Endemic human monkeypox, democratic Republic of Congo, 2001–2004
  27. The role of squirrels in sustaining monkeypox virus transmission.
  28. Clinical manifestations of human monkeypox influenced by route of infection
  29. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo
  30. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation
  31. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report
  32. Analysis of the monkeypox virus genome
  33. Status of human monkeypox: clinical disease, epidemiology and research
  34. Human monkeypox.
  35. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018
  36. Detection of monkeypox virus with real-time PCR assays
  37. Ecological niche and geographic distribution of human monkeypox in Africa
  38. monkeypox: an emerging infection for humans?
  39. Modelling human-to-human transmission of monkeypox
  40. Update: multistate outbreak of monkeypox–Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003
  41. Discovery of monkeypox in Sudan
  42. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa.
  43. Isolation of monkeypox virus from wild squirrel infected in nature.
  44. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo
  45. Multistate outbreak of monkeypox–Illinois, Indiana, and Wisconsin, 2003
  46. Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus
  47. Human monkeypox infection: a family cluster in the midwestern United States
  48. A case of imported monkeypox in Singapore
  49. Exportation of monkeypox virus from the African continent
  50. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
  51. The changing epidemiology of human monkeypox—A potential threat? A systematic review
  52. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001
  53. Human monkeypox and smallpox viruses: genomic comparison
  54. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
  55. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy
  56. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention
  57. … of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 …
  58. Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire.
  59. Vaccinating against monkeypox in the Democratic Republic of the Congo
  60. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
  61. monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak
  62. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection
  63. Imported monkeypox, Singapore
  64. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox
  65. Subunit recombinant vaccine protects against monkeypox
  66. Spectrum of infection and risk factors for human monkeypox, United States, 2003
  67. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017–2020
  68. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox
  69. Four generations of probable person-to-person transmission of human monkeypox
  70. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012
  71. Poxvirus dilemmas—monkeypox, smallpox, and biologic terrorism
  72. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis)
  73. monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire.
  74. monkeypox re-emergence in Africa: a call to expand the concept and practice of One Health
  75. monkeypox virus and insights into its immunomodulatory proteins
  76. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection
  77. A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus
  78. monkeypox virus in Nigeria: infection biology, epidemiology, and evolution
  79. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo
  80. Isolation and properties of the causal agent of a new variola-like disease (monkeypox) in man
  81. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021
  82. Occupational risks during a monkeypox outbreak, Wisconsin, 2003
  83. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus
  84. Emerging diseases—the monkeypox epidemic in the Democratic Republic of the Congo
  85. Ecology and geography of human monkeypox case occurrences across Africa
  86. monkeypox: an epidemiologic and clinical comparison of African and US disease
  87. Detection of human monkeypox in the Republic of the Congo following intensive community education
  88. Smallpox and monkeypox in non-human primates
  89. Outbreaks of human monkeypox after cessation of smallpox vaccination
  90. Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus
  91. Human monkeypox–After 40 years, an unintended consequence of smallpox eradication
  92. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246
  93. A game-theoretic model of monkeypox to assess vaccination strategies
  94. monkeypox virus emergence in wild chimpanzees reveals distinct clinical outcomes and viral diversity
  95. Fatal monkeypox in wild-living sooty mangabey, Cote d’Ivoire, 2012
  96. In vitro efficacy of ST246 against smallpox and monkeypox
  97. Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003.
  98. Serological survey for human monkeypox infections in a selected population in Zaire.
  99. Intrafamily transmission of monkeypox virus, Central African Republic, 2018
  100. Genomic characterisation of human monkeypox virus in Nigeria
  101. Human monkeypox: current state of knowledge and implications for the future
  102. A phylogeographic investigation of African monkeypox
  103. Human infection with monkeypox virus: laboratory investigation of six cases in West Africa
  104. Experimental infection of prairie dogs with monkeypox virus
  105. monkeypox virus: histologic, immunohistochemical and electron‐microscopic findings
  106. Outbreaks of monkeypox and serological surveys in nonhuman primates
  107. Using remote sensing to map the risk of human monkeypox virus in the Congo Basin
  108. Use of surveillance outbreak response management and analysis system for human monkeypox outbreak, Nigeria, 2017–2019
  109. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005
  110. Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States
  111. Retrospective analysis of monkeypox infection
  112. monkeypox: a review of the history and emergence in the Western hemisphere
  113. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus
  114. Prevalence of antibodies against orthopoxviruses among residents of Likouala region, Republic of Congo: evidence for monkeypox virus exposure
  115. A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus
  116. Knowledge of human monkeypox viral infection among general practitioners: a cross-sectional study in Indonesia
  117. Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation
  118. Assessing monkeypox virus prevalence in small mammals at the human–animal interface in the Democratic Republic of the Congo
  119. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques
  120. Comparison of monkeypox Viruses Pathogenesis in Mice by In Vivo Imaging
  121. Strengthening of surveillance during monkeypox outbreak, Republic of the Congo, 2017
  122. Intragenornic sequence transposition in monkeypox virus
  123. Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different
  124. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models
  125. Phylogenetic and ecologic perspectives of a monkeypox outbreak, southern Sudan, 2005
  126. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus
  127. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers
  128. Human monkeypox–Kasai Oriental, Democratic Republic of…
  129. Epidemiologic and ecologic investigations of monkeypox, Likouala Department, Republic of the Congo, 2017
  130. Notes from the field: Responding to an outbreak of monkeypox using the one health approach—Nigeria, 2017–2018
  131. Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response
  132. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo
  133. Comparative pathology of North American and central African strains of monkeypox virus in a ground squirrel model of the disease.
  134. Human monkeypox transmitted by a chimpanzee in a tropical rain-forest area of Zaire
  135. monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection
  136. Susceptibility of some rodent species to monkeypox virus, and course of the infection
  137. A nosocomial outbreak of human monkeypox in the Central African Republic
  138. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox
  139. Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo
  140. Comparison of white pock (h) mutants of monkeypox virus with parental monkeypox and with variola-like viruses isolated from animals
  141. Comparative pathology of smallpox and monkeypox in man and macaques
  142. Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection
  143. US monkeypox outbreak traced to Wisconsin pet dealer
  144. Susceptibility of Marmosets (Callithrix jacchus) to monkeypox Virus: A Low Dose Prospective Model for monkeypox and Smallpox Disease
  145. Whither monkeypox vaccination
  146. Clinical features and management of human monkeypox: a retrospective observational study in the UK
  147. monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan® assays on the Roche LightCycler
  148. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo
  149. monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo
  150. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases
  151. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses
  152. Effects of georeferencing effort on mapping monkeypox case distributions and transmission risk
  153. … kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling responses as compared to West African monkeypox …
  154. Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques
  155. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge
  156. Virulence and pathophysiology of the Congo Basin and West African strains of monkeypox virus in non-human primates
  157. Presumptive risk factors for monkeypox in rural communities in the Democratic Republic of the Congo
  158. Twelve cases of monkeypox virus outbreak in Bangassou District (Central African Republic) in December 2015
  159. A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
  160. Evaluation of the GeneXpert for human monkeypox diagnosis
  161. Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus
  162. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease
  163. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA
  164. Enhancing health care worker ability to detect and care for patients with monkeypox in the Democratic Republic of the Congo
  165. Recombinase polymerase amplification assay for rapid detection of monkeypox virus
  166. Human monkeypox in Sierra Leone after 44-year absence of reported cases
  167. Studies on monkeypox virus
  168. Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Aerosolized monkeypox Virus
  169. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria
  170. Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin
  171. Seven monkeypox cases are confirmed in England
  172. Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes
  173. Comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route
  174. monkeypox virus phylogenetic similarities between a human case detected in Cameroon in 2018 and the 2017-2018 outbreak in Nigeria
  175. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic
  176. monkeypox and whitepox viruses in West and Central Africa
  177. Confidence in managing human monkeypox cases in Asia: A cross-sectional survey among general practitioners in Indonesia
  178. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values
  179. The evolving epidemiology of human monkeypox–questions still to be answered
  180. Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system
  181. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions
  182. Human monkeypox–Kasai Oriental, Zaire, 1996-1997
  183. Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus
  184. Evaluation of monkeypox disease progression by molecular imaging
  185. A Novel International monkeypox Outbreak
  186. monkeypox in a Traveler Returning from Nigeria—Dallas, Texas, July 2021
  187. Mapping monkeypox transmission risk through time and space in the Congo Basin
  188. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge
  189. Case report: Human monkeypox in the kivus, a conflict region of the Democratic Republic of the Congo
  190. monkeypox outbreak a reminder of emerging infections vulnerabilities
  191. Specific detection of monkeypox virus by polymerase chain reaction
  192. Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia
  193. Characterization of monkeypox virus infection in African rope squirrels (Funisciurus sp.)
  194. monkeypox—Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era
  195. Molecular evidence of human monkeypox virus infection, Sierra Leone
  196. Ghosts of infections past: using archival samples to understand a century of monkeypox virus prevalence among host communities across space and time
  197. Improving the care and treatment of monkeypox patients in low-resource settings: applying evidence from contemporary biomedical and smallpox biodefense …
  198. Evolution of synonymous codon usage bias in west African and central African strains of monkeypox virus
  199. monkeypox virus infections in small animal models for evaluation of anti-poxvirus agents
  200. The histopathology and electron microscopy of a human monkeypox lesion
  201. Epidemiology, Diagnosis, and Control of monkeypox Disease: A comprehensive Review
  202. Inhalational monkeypox virus infection in cynomolgus macaques
  203. monkeypox-specific antibodies in human and simian sera from the Ivory Coast and Nigeria
  204. Inhibition of monkeypox virus replication by RNA interference
  205. Clinical course and outcome of human monkeypox in Nigeria
  206. monkeypox in the United States: an occupational health look at the first cases
  207. Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay
  208. Independent evolution of monkeypox and variola viruses
  209. Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity
  210. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of …
  211. monkeypox disease transmission in an experimental setting: prairie dog animal model
  212. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions
  213. Laboratory Investigations of African Pouched Rats (Cricetomys gambianus) as a Potential Reservoir Host Species for monkeypox Virus
  214. Temporal and spatial dynamics of monkeypox in Democratic Republic of Congo, 2000–2015
  215. Evolution of a disease surveillance system: an increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001–2013
  216. Evidence for recent genetic variation in monkeypox viruses
  217. Comparison of multiplexed immunofluorescence imaging to chromogenic immunohistochemistry of skin biomarkers in response to monkeypox virus infection
  218. Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (smallpox, monkeypox and cowpox)
  219. Three specific antigens produced in vaccinia, variola, and monkeypox infections
  220. The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon
  221. Comparison of West African and Congo Basin monkeypox viruses in BALB/c and C57BL/6 mice
  222. In vitro inhibition of monkeypox virus production and spread by Interferon-β
  223. Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes
  224. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal monkeypox Virus Animal Model
  225. Elucidating the role of the complement control protein in monkeypox pathogenicity
  226. monkeypox
  227. Human monkeypox
  228. monkeypox= Orthopoxvirose simienne
  229. Fatal monkeypox in a child in Kikwit, Zaire
  230. Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease
  231. monkeypox outbreak among pet owners
  232. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
  233. monkeypox without exanthem
  234. monkeypox transmission among international travellers—serious monkey business?
  235. Nucleotide sequence of the thymidine kinase gene region of monkeypox and variola viruses
  236. monkeypox Virus
  237. Importance of epidemiological research of monkeypox: is incidence increasing?
  238. Evasion of the innate immune type I interferon system by monkeypox virus
  239. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus
  240. Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations
  241. The 2017 human monkeypox outbreak in Nigeria—report of outbreak experience and response in the Niger Delta University Teaching Hospital, Bayelsa State …
  242. Extensive Lesions of monkeypox in a Prairie Dog (Cynomys sp.)
  243. Can variola-like viruses be derived from monkeypox virus? An investigation based on DNA mapping
  244. Immunological Memory after Exposure to Variola Virusm monkeypox Virus, and Vaccinia Virus
  245. monkeypox virus as a source of whitepox viruses
  246. Learning from experience: the public health response to West Nile virus, SARS, monkeypox, and hepatitis A outbreaks in the United States
  247. A Tale of Two Viruses: Coinfections of monkeypox and Varicella Zoster Virus in the Democratic Republic of Congo
  248. Imported monkeypox from International Traveler, Maryland, USA, 2021
  249. Susceptibility of monkeypox virus aerosol suspensions in a rotating chamber
  250. Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa
  251. Clinical and Epidemiological Findings from Enhanced monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011–2015
  252. Differentiation of variola, monkeypox, and vaccinia antisera by radioimmunoassay
  253. monkeypox spreads as US public-health system plays catch-up
  254. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination
  255. Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess monkeypox Drug Efficacy
  256. monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation
  257. Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African …
  258. The Role of the Obstetrician–Gynecologist in Emerging Infectious Diseases: monkeypox and Pregnancy
  259. EVALUATION OF monkeypox VIRUS INFECTION OF BLACK-TAILED PRAIRIE DOGS (CYNOMYS LUDOVICIANUS) USING IN VIVO BIOLUMINESCENT …
  260. monkeypox rash severity and animal exposures in the Democratic Republic of the Congo
  261. Emergence of human monkeypox in west Africa
  262. monkeypox: What do we know about the outbreaks in Europe and North America?
  263. Serological relatedness of monkeypox, variola, and vaccinia viruses
  264. Comparison of monkeypox virus clade kinetics and pathology within the prairie dog animal model using a serial sacrifice study design
  265. monkeypox: A Neglected Viral Zoonotic Disease
  266. Human monkeypox and other poxvirus infections of man
  267. … tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high-and low-dose monkeypox …
  268. The virion and soluble antigen proteins of variola, monkeypox, and vaccinia viruses
  269. Effects of treatment delay on efficacy of tecovirimat following lethal aerosol monkeypox virus challenge in cynomolgus macaques
  270. Lay media reporting of monkeypox in Nigeria
  271. Modeling the transmission dynamics of the monkeypox virus infection with treatment and vaccination interventions
  272. Loop‐mediated isothermal amplification‐based diagnostic assay for monkeypox virus infections
  273. Report of monkeypox cases in 2018 in the United Kingdom
  274. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo
  275. Expansion, reexpansion, and recall-like expansion of Vγ2Vδ2 T cells in smallpox vaccination and monkeypox virus infection
  276. Genus Orthopoxvirus: monkeypox virus
  277. Diagnosis and assessment of monkeypox virus (MPXV) infection by quantitative PCR assay: differentiation of Congo Basin and West African MPXV strains
  278. ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification
  279. Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein
  280. Whitepox virus isolated from hamsters inoculated with monkeypox virus
  281. Variola or a severe case of varicella? A case of human variola due to monkeypox virus in a child from the Cameroon
  282. Transmission dynamics of monkeypox virus: a mathematical modelling approach
  283. Attenuation of monkeypox virus by deletion of genomic regions
  284. … with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus …
  285. Further Assessment of monkeypox Virus Infection in Gambian Pouched Rats (Cricetomys gambianus) Using In Vivo Bioluminescent Imaging
  286. monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus
  287. Species-specific differentiation of variola, monkeypox, and varicella-zoster viruses by multiplex real-time PCR assay
  288. monkeypox outbreak diagnostics and implications for vaccine protective effect
  289. … of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox
  290. monkeypox virus host factor screen using haploid cells identifies essential role of GARP complex in extracellular virus formation
  291. Emerging infections and pregnancy: West Nile virus, monkeypox, severe acute respiratory syndrome, and bioterrorism
  292. Orthopoxviruses: vaccinia (smallpox vaccine), variola (smallpox), monkeypox, and cowpox
  293. Generalized monkeypox in orally infected rabbits and white mice
  294. Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey
  295. Cytokine modulation correlates with severity of monkeypox disease in humans
  296. … of D-and L-2-cyclopentenone and their utility for the synthesis of carbocyclic antiviral nucleosides against orthopox viruses (smallpox, monkeypox, and cowpox virus)
  297. PLAQUE MORPHOLOGY OF monkeypox VIRUS AS AN AID TO STRAIN IDENTIFICATION
  298. Multistate outbreak of monkeypox-Illinois, Indiana, and Wisconsin, 2003
  299. Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus
  300. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
  301. Stability analysis for the equilibria of a monkeypox model
  302. monkeypox chez l’homme, 1970-79
  303. Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo
  304. Characterization of Macaque Pulmonary Fluid Proteome during monkeypox Infection
  305. Modelling HIV/AIDS and monkeypox co-infection
  306. … -orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox …
  307. Substrate specificity of homogeneous monkeypox virus uracil-DNA glycosylase
  308. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27
  309. A study of the specificities of sequential antisera to variola and monkeypox viruses by radioimmunoassay
  310. monkeypox in Nigeria: A case report of re-emerged disease outbreak
  311. Toward Understanding the Outcomes of monkeypox Infection in Human Pregnancy
  312. Can culling to prevent monkeypox infection be counter-productive? Scenarios from a theoretical model
  313. Human monkeypox hits beleaguered Zaire
  314. monkeypox in the Democratic Republic of the Congo (former Zaire)
  315. Do monkeypox Exposures Vary by Ethnicity? Comparison of Aka and Bantu Suspected monkeypox Cases
  316. monkeypox virus: responses of infection in chick embryos
  317. Induction, Course, and Transmissibility of monkeypox in the Baboon (Papio cynocephalus)
  318. … of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox …
  319. Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone
  320. IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal monkeypox Challenge Prairie Dog …
  321. Identification and whole-genome sequencing of a monkeypox virus strain isolated in Israel
  322. Nucleotide sequence comparison of homologous genomic regions from variola, monkeypox, and vaccinia viruses
  323. monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions
  324. monkeypox virus viral chemokine inhibitor (MPV vCCI), a potent inhibitor of rhesus macrophage inflammatory protein-1
  325. Assessment of media reportage of monkeypox in southern Nigeria
  326. Emergence of monkeypox—West and Central Africa, 1970–2017
  327. A Case Report of monkeypox in a 4-Year-Old Boy from the DR Congo: Challenges of Diagnosis and Management
  328. Electron-microscopical observations on the development of vaccinia, cowpox and monkeypox viruses in pig skin.
  329. Anticipating smallpox and monkeypox outbreaks: Complications of the smallpox vaccine
  330. Prairie-dog model offers hope of tackling monkeypox virus
  331. Analgesia during monkeypox virus experimental challenge studies in prairie dogs (Cynomys ludovicianus)
  332. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge
  333. A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox
  334. Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus
  335. Clinical and epidemiologic findings from enhanced monkeypox surveillance in Tshuapa Province, Democratic Republic of the Congo during 2011–2015
  336. Laboratory testing for the monkeypox virus: interim guidance, 23 May 2022
  337. Human monkeypox in Kasai Oriental, Democratic Republic of the Congo (former Zaire): preliminary report of October 1997 investigation
  338. Successful treatment in the monkeypox and variola primate models of smallpox by the oral drug ST-246
  339. Development of prophylactics and therapeutics against the smallpox and monkeypox biothreat agents
  340. Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in Cameroon
  341. monkeypox: features of spread after cancellation of mandatory pox immunization
  342. Monoclonal antibodies to a monkeypox virus polypeptide determinant
  343. Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination
  344. Re-emergence of monkeypox in Nigeria: A cause for concern and public enlightenment
  345. Surveillance, case investigation and contact tracing for monkeypox: interim guidance, 22 May 2022
  346. An adult patient with suspected of monkeypox infection differential diagnosed to chickenpox
  347. The polypeptides of monkeypox virus: I. Analysis of the polypeptide synthesis of MPV by SDS-PAGE and by two-dimensional electrophoresis
  348. A Neuro-Fussy Based Model for Diagnosis of monkeypox Diseases
  349. Poxvirus antigen staining of immune cells as a biomarker to predict disease outcome in monkeypox and cowpox virus infection in non-human primates
  350. monkeypox outbreak diagnostics and implications for vaccine protective effect
  351. Descriptive epidemiology of monkeypox in Nigeria, September 2017–June 2019
  352. In vitro growth characteristics of monkeypox virus
  353. Human monkeypox
  354. … IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus …
  355. monkeypox, Marshfield Clinic and the Internet: leveraging information technology for public health
  356. Finishing monkeypox genomes from short reads: assembly analysis and a neural network method
  357. Unveiling the Arcane of an Elusive Virus from the Heart of the African Continent: The monkeypox
  358. monkeypox virus (MPV) I. Propagation, purification, and further characterization
  359. The monkeypox virus outbreak: Reflections from the frontlines
  360. Increase seen in monkeypox cases
  361. Transmission dynamics of monkeypox virus: a mathematical modelling approach
  362. monkeypox, 1991= Orthopoxvirose simienne, 1991
  363. US doctors investigate more than 50 possible cases of monkeypox
  364. monkeypox multi-country outbreak
  365. [18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of monkeypox Virus Infection
  366. monkeypox detection in maculopapular lesions in two young Pygmies in the Central African Republic
  367. SARS: here to stay? monkeypox: beware of exotic pets.
  368. Differential inhibitory effects of 5-bromodeoxyuridine on vaccinia and monkeypox viruses
  369. Human monkeypox in Kasai Oriental, Zaire (1996-1997)
  370. Reminiscing the recent incidence of monkeypox in Nigeria: Its ecologic-epidemiology and literature review
  371. EARLY WARNING OF monkeypox DISEASE IN INDONESIA
  372. monkeypox and Other Emerging Orthopoxvirus Infections
  373. Human monkeypox in West Africa
  374. Emergence of monkeypox in West Africa and Central Africa, 1970-2017/Emergence de l’orthopoxvirose simienne en Afrique de l’Ouest et en Afrique centrale, 1970 …
  375. KNOWLEDGE AND PERCEPTION OF monkeypox DISEASE IN YENAGOA, BAYELSA STATE
  376. monkeypox virus as a potential source of variola virus
  377. An Early Transmissibility Estimate for the 2022 monkeypox Outbreak
  378. Update: Multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003
  379. Sixty seconds on… monkeypox
  380. Training health workers for enhanced monkeypox surveillance, Democratic Republic of the Congo
  381. Human monkeypox in the Democratic Republic of Congo: Presentation, Prediction and Animal Exposures Associated with Rash Severity
  382. The changing epidemiology of human monkeypox—A potential threat? A systematic review| PLOS Neglected Tropical Diseases
  383. Sounding the alarm: Defining thresholds to trigger a public health response to monkeypox
  384. Identification of human pathogenic variola and monkeypox viruses by real-time polymerase chain reaction
  385. Physicians’ willingness to be vaccinated with a smallpox vaccine to prevent monkeypox viral infection: A cross-sectional study in Indonesia
  386. Major Increase in Human monkeypox Incidence 30 Years After Smallpox Vaccination Campaigns Cease in the Democratic Republic of Congo: AW Rimoin et al. PNAS …
  387. CDC information on monkeypox virus
  388. Research progress in monkeypox virus detection
  389. monkeypox Virus
  390. monkeypox virus (MPV) II. Uncoating and nucleic acid synthesis
  391. Triage of a febrile patient with a rash: a comparison of chickenpox, monkeypox, and smallpox
  392. A Case of monkeypox in a Returned Traveler
  393. Correction for Hutson et al.,“Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal monkeypox Virus Animal Model”
  394. Optimization of automated segmentation of monkeypox virus-induced lung lesions from normal lung CT images using hard C-means algorithm
  395. Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques
  396. Modelling human-to-human transmission of monkeypox Addendum
  397. monkeypox= Orthopoxvirose simienne
  398. Modelling human-to-human transmission of monkeypox Supporting information
  399. monkeypox not mutating
  400. monkeypox on the rise
  401. Human monkeypox: update 1978
  402. Scrutinizing surface glycoproteins and poxin-schlafen protein to design a heterologous recombinant vaccine against monkeypox virus
  403. Emerging monkeypox
  404. monkeypox Virus
  405. A game-theoretic model of monkeypox to
  406. monkeypox Virus Hosts and Transmission Routes: A Systematic Review of a Zoonotic Pathogen
  407. Plans to minimize the risk of viral infections–it’s all a matter of susceptibility part II: SARS, West Nile, and monkeypox
  408. HUMAN monkeypox: UPDATE= ORTHOPOXVIROSE SIMIENNE DE L’HOMME: MISE À JOUR
  409. Post-Exposure Vaccination with a Highly Attenuated Vaccinia Vaccine, LC16m8, for Protection of Nonhuman Primates from monkeypox
  410. Patient safety tools: SARS, smallpox, monkeypox, and avian flu
  411. On alert for monkeypox
  412. An Outbreak of monkeypox in Doedain District, Rivercess County, Liberia, June, 2017
  413. Human monkeypox, A Newly
  414. High acceptance of new monkeypox vaccine among GPs in Indonesia
  415. Generation and characterization of specific monoclonal antibodies against monkeypox virus
  416. Early Release-Reemergence of Human monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017–2020
  417. The World Health Organization’s monkeypox surveillance programme, 1980-86
  418. First US monkeypox cases crop up in the Midwest
  419. Descriptive epidemiology of monkeypox outbreak in Bayelsa State South-South Nigeria, November 2017
  420. Emergence of monkeypox in West and Central Africa, 1970–2017–Émergence de l’orthopoxvirose simienne en Afrique de l’Ouest et en Afrique centrale, 1970 …
  421. Human monkeypox and Human Immunodeficiency Virus Co-infection: A Case Series in Makurdi, Benue State, Nigeria
  422. Interim Case Definition for Animal Cases of monkeypox
  423. Design and optimization of a monkeypox virus specific serological assay
  424. RESEARCH monkeypox Transmission and Pathogenesis in Prairie Dogs
  425. Human monkeypox in the Kivus, a conflict region of The Democratic Republic of the Congo
  426. A COMPARATIVE ANALYSIS OF monkeypox AND VARIOLA VIRUS DNA (VIRUS).
  427. Le virus monkeypox et whitepox en Afrique occidentale et centrale
  428. Mapping monkeypox Transmission Risk through Time and Space in the Congo
  429. Ecological Niche and Geographic Distribution of Human monkeypox in
  430. Human monkeypox in the US: investigations confirm that multiple animal species are susceptible to infection
  431. Proteomic Basis of the Antibody Response to monkeypox Virus Infection Examined in
  432. US monkeypox outbreak traced to Wisconsin pet dealer.(Infectious Diseases)
  433. Comparative study of variola virus and monkeypox virus interferon-gamma-binding
  434. Ocular complications associated with acute monkeypox virus infection, DRC
  435. Generalized monkeypox in young rabbits and white mice infected orally.
  436. An Investigation into the Historical Distribution, Prevalence, and Host Community of monkeypox Virus (MPXV) Among Funisciurus Museum Skin Specimens …
  437. Orthopoxviruses: Variola, Vaccinia, Cowpox, and monkeypox
  438. Report on the 2003 Outbreak of monkeypox in the Western Hemisphere
  439. SMALLPOX: POST-ERADICATION SURVEILLANCE: First isolation of monkeypox virus from a wild animal infected in nature
  440. Analysis of the complete genomes of rabbitpox virus utrecht and three West African isolates of monkeypox virus
  441. … COMPARATIVE MOLECULAR BIOLOGY BETWEEN AN ONCOGENIC POXVIRUS (YABA) AND AN ORTHOPOXVIRUS (monkeypox)(PROTEINS, DNA, CLONING) …
  442. A One Health Perspective on Disease Dynamics: Human monkeypox Transmission in Sankuru District, Democratic Republic of Congo
  443. Rapid Identification of monkeypox Virus using Tandem Repeats with Insertion, Deletion and SNPs
  444. SMALLPOX: POST-ERADICATION SURVEILLANCE: Squirrels proved to maintain monkeypox virus transmission in nature
  445. Smallpox, vaccinia and human monkeypox viruses
  446. Systems kinomics demonstrates Congo Basin monkeypox virus infection selectively modulates host cell signaling re…
  447. Communication with the Public in Outbreaks of West Nile Virus, SARS, monkeypox, and Hepatitis A in the United St…
  448. Public Health Assessment in Outbreaks of West Nile Virus, SARS, monkeypox, and Hepatitis A in the United States
  449. monkeypox detection in rodents using real-time 3’minor groove binder Taqman assays on the Roche LightCycler, Laboratory Investigation 84: 1200-1208
  450. Utilization of the prairie dog (Cynomys sp.) animal model for the study of monkeypox virus: pathogenicity differences between viral clades and the effect of …
  451. monkeypox virus infection of rhesus macaques induces massive expansion of NK cells, but suppresses NK cell function (P4369)
  452. Correction to Comparative Proteomics of Human monkeypox and Vaccinia Intracellular Mature and Extracellular Enveloped Virions
  453. COS 88-9: monkeypox in the Democratic Republic of Congo: Transmission dynamics of a re-emerging zoonosis
Related Posts

Purgatives

Anxiolytic

Liver Regeneration

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping